GlassScriptPhysician profile
Heather R Bishop
NPI 1114392313
$8,614.69
in general payments reported to CMS, 2019-2025
49 companies · $671 in 2025
The $671 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,804 · 2022: $2,107 · 2023: $1,942 · 2024: $1,091 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,703.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,441.72 | 2021-2024 | |
| Novo Nordisk INC | $1,021.98 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $958.20 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $703.59 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $482.31 | 2021-2024 | Trintellix |
| Axsome Therapeutics, INC. | $374.05 | 2022-2025 | Auvelity, Symbravo |
| Novartis Pharmaceuticals Corporation | $313.96 | 2021-2022 | |
| Dexcom, INC. | $301.16 | 2021-2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $269.76 | 2021-2024 | Rexulti |
| Esperion Therapeutics, INC. | $257.76 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $231.50 | 2021-2024 | Xifaxan |
| Biohaven Pharmaceuticals, INC. | $230.94 | 2021 | |
| Bausch Health US, LLC | $228.77 | 2021-2023 | Aplenzin |
| Amgen INC. | $212.80 | 2021-2024 | Repatha, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $173.12 | 2022 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $109.80 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Antares Pharma, INC. | $108.85 | 2021-2023 | Xyosted, Tlando, Nocdurna |
| Corcept Therapeutics | $103.69 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $98.98 | 2021-2023 | Verquvo, Belsomra, Steglatro |
| Idorsia Pharmaceuticals US INC | $86.38 | 2022-2024 | Quviviq |
| Shield Therapeutics INC | $83.19 | 2023-2024 | Accrufer |
| Amarin Pharma, INC. | $64.39 | 2021 | |
| Sanofi-Aventis U.S. LLC | $58.20 | 2021 | |
| Arbor Pharmaceuticals, INC. | $56.31 | 2021-2022 | |
| Mylan Specialty L.P. | $51.30 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.31 | 2022 | |
| Halozyme INC | $43.76 | 2023 | |
| Xeris Pharmaceuticals, INC. | $38.37 | 2023 | Gvoke Hypopen |
| Inogen, INC. | $36.93 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Almatica Pharma LLC | $33.91 | 2021-2022 | |
| Pfizer INC. | $33.34 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $31.34 | 2022 | |
| Phathom Pharmaceuticals, INC. | $30.68 | 2025 | Voquezna |
| Clarus Therapeutics INC. | $30.67 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $26.99 | 2025 | Caplyta |
| Kowa Pharmaceuticals America, INC. | $26.83 | 2021 | |
| Eisai INC. | $24.63 | 2021 | |
| Inspire Medical Systems, INC. | $24.00 | 2025 | Inspire |
| Vanda Pharmaceuticals INC. | $23.72 | 2025 | Hetlioz, Fanapt |
| Tris Pharma INC | $20.78 | 2023 | Dyanavel Xr |
| Genzyme Corporation | $18.48 | 2021 | |
| Intra-Sana Laboratories | $16.89 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Medtronic, INC. | $14.98 | 2024 | Intellis Adaptivestim |
| Teva Pharmaceuticals USA, INC. | $14.34 | 2021 | |
| Hikma Pharmaceuticals USA | $13.71 | 2023 | Ryaltris, Mitigare |
| Lundbeck LLC | $11.89 | 2022 | |
| Biodelivery Sciences International, INC. | $11.72 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.14 | 2021 | |
| Genentech USA, INC. | $4.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.